Evidence map›Paper›PMID 22869728›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice.

Julia Grizenkova, Shaheen Akhtar, Holger Hummerich, Andrew Tomlinson, Emmanuel A Asante, Adam Wenborn, Jérémie Fizet, Mark Poulter, Frances K Wiseman, Elizabeth M C Fisher and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genetics of prion diseases.Current opinion in genetics & development · 2013
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Julia GrizenkovaMedical Research Council (MRC) Prion Unit, University College London (UCL) Institute of Neurology, London, United Kingdom.
Shaheen Akhtar
Holger Hummerich
Andrew Tomlinson
Emmanuel A Asante
Adam Wenborn
Jérémie Fizet
Mark Poulter
Frances K Wiseman
Elizabeth M C Fisher
Victor L J Tybulewicz
Sebastian Brandner
John Collinge
Sarah E Lloyd
Medical Research Council · GBUniversity College London · GBMRC Prion Unit · GBThe Francis Crick Institute · GB

Funding

Medical Research Council G0601056Medical Research Council MC_U117527252Medical Research Council MC_U123160651Medical Research Council MC_U123160652Medical Research Council MC_U123160653Medical Research Council MC_U123192748Medical Research Council U117527252
6 · The paper itself

Abstract

Prion diseases are fatal neurodegenerative disorders that include bovine spongiform encephalopathy (BSE) and scrapie in animals and Creutzfeldt-Jakob disease (CJD) in humans. They are characterized by long incubation periods, variation in which is determined by many factors including genetic background. In some cases it is possible that incubation time may be directly correlated to the level of gene expression. To test this hypothesis, we combined incubation time data from five different inbred lines of mice with quantitative gene expression profiling in normal brains and identified five genes with expression levels that correlate with incubation time. One of these genes, Hspa13 (Stch), is a member of the Hsp70 family of ATPase heat shock proteins, which have been previously implicated in prion propagation. To test whether Hspa13 plays a causal role in determining the incubation period, we tested two overexpressing mouse models. The Tc1 human chromosome 21 (Hsa21) transchromosomic mouse model of Down syndrome is trisomic for many Hsa21 genes including Hspa13 and following Chandler/Rocky Mountain Laboratory (RML) prion inoculation, shows a 4% reduction in incubation time. Furthermore, a transgenic model with eightfold overexpression of mouse Hspa13 exhibited highly significant reductions in incubation time of 16, 15, and 7% following infection with Chandler/RML, ME7, and MRC2 prion strains, respectively. These data further implicate Hsp70-like molecular chaperones in protein misfolding disorders such as prion disease.

Indexed as

Gene Expression RegulationAdenosine TriphosphatasesAnimalsHSP70 Heat-Shock ProteinsHumansMiceMice, Inbred C57BLMice, Inbred CBAMice, TransgenicModels, GeneticNeuronsOligonucleotide Array Sequence AnalysisPhenotypePrion DiseasesPrionsRNA, ComplementaryAdenosine TriphosphatasesHSP70 Heat-Shock ProteinsHspa13 protein, mousePrionsRNA, Complementary

Identifiers

PMID22869728
PMCPMC3427081
OpenAlexW2009539247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.